1230136

AstraZeneca Pharmaceuticals LP — FEI 1000198729

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gaithersburg, MD (United States)

Additional Details

Sponsor, Contract Research Organization